Pluristem Therapeutics Appoints Diabetic Neuropathy and Vascular Disease Expert, Dr. Aristidis Veves, to Its Scientific Advisory Board

HAIFA, Israel--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it appointed Dr. Aristidis Veves to the company’s Scientific Advisory Board.

MORE ON THIS TOPIC